Market Cap 1.85B
Revenue (ttm) 1.23B
Net Income (ttm) -87.29M
EPS (ttm) N/A
PE Ratio 37.10
Forward PE 38.35
Profit Margin -7.11%
Debt to Equity Ratio 0.00
Volume 457,200
Avg Vol 364,576
Day's Range N/A - N/A
Shares Out 63.32M
Stochastic %K 18%
Beta 0.96
Analysts Strong Sell
Price Target $33.33

Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its da...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 404 810 0089
Address:
300 Galleria Parkway SE, Suite 800, Atlanta, United States
JarvisFlow
JarvisFlow Nov. 14 at 5:55 PM
Truist Securities has updated their rating for Guardian Pharmacy Service ( $GRDN ) to Buy with a price target of 34.
0 · Reply
_www_larval_com_
_www_larval_com_ Nov. 11 at 4:22 PM
$GRDN just popped 7% higher to 22% (~325Kv) moments ago, follow for more volatility.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 10 at 9:24 PM
0 · Reply
CatCapital_ai
CatCapital_ai Nov. 10 at 9:13 PM
$GRDN Earnings - Q3/2025 Revenue: $377.43M ✅ vs. $355.2M est. EPS: $0.25 ✅ vs. $0.24 est. Guardian Pharmacy delivers strong Q3 results, citing disciplined execution and growth momentum. Company raises full-year revenue and EBITDA guidance; announces acquisition in Oregon and new share sale filings.
0 · Reply
Arcides
Arcides Oct. 17 at 3:17 PM
$GRDN this stock is holding good on a key level, volatility is compresing.
0 · Reply
JarvisFlow
JarvisFlow Oct. 10 at 5:49 PM
Oppenheimer has adjusted their stance on Guardian Pharmacy Service ( $GRDN ), setting the rating to Outperform with a target price of 30.
0 · Reply
scientificway
scientificway Sep. 3 at 4:14 PM
$GRDN Chance to get in before it shoots up
1 · Reply
scientificway
scientificway Aug. 27 at 5:50 PM
$GRDN strong buy, XTNT revenue up year over year. showing a strong support here and most likely going up from here.
0 · Reply
CapitalTrekker
CapitalTrekker Aug. 27 at 6:51 AM
$GRDN momentum slowing down, needs strength to push higher.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 12:14 PM
$GRDN https://www.benzinga.com/pressreleases/25/08/b46824763/guardian-pharmacy-services-strengthens-pacific-northwest-presence-with-acquisition-of-oregon-based
0 · Reply
Latest News on GRDN
U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Sep 28, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

BIOA BKV FLX FVR PC SARO


Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Sep 26, 2024, 10:50 AM EDT - 1 year ago

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut


Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

Sep 25, 2024, 9:45 PM EDT - 1 year ago

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO


Guardian Pharmacy Services' IPO Valuation Looks Pricey

Sep 18, 2024, 11:46 AM EDT - 1 year ago

Guardian Pharmacy Services' IPO Valuation Looks Pricey


Guardian Pharmacy targets up to $974 mln valuation in US IPO

Sep 16, 2024, 12:33 PM EDT - 1 year ago

Guardian Pharmacy targets up to $974 mln valuation in US IPO


Guardian Pharmacy Services Launches U.S. IPO Effort

Oct 4, 2023, 1:16 PM EDT - 2 years ago

Guardian Pharmacy Services Launches U.S. IPO Effort


JarvisFlow
JarvisFlow Nov. 14 at 5:55 PM
Truist Securities has updated their rating for Guardian Pharmacy Service ( $GRDN ) to Buy with a price target of 34.
0 · Reply
_www_larval_com_
_www_larval_com_ Nov. 11 at 4:22 PM
$GRDN just popped 7% higher to 22% (~325Kv) moments ago, follow for more volatility.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 10 at 9:24 PM
0 · Reply
CatCapital_ai
CatCapital_ai Nov. 10 at 9:13 PM
$GRDN Earnings - Q3/2025 Revenue: $377.43M ✅ vs. $355.2M est. EPS: $0.25 ✅ vs. $0.24 est. Guardian Pharmacy delivers strong Q3 results, citing disciplined execution and growth momentum. Company raises full-year revenue and EBITDA guidance; announces acquisition in Oregon and new share sale filings.
0 · Reply
Arcides
Arcides Oct. 17 at 3:17 PM
$GRDN this stock is holding good on a key level, volatility is compresing.
0 · Reply
JarvisFlow
JarvisFlow Oct. 10 at 5:49 PM
Oppenheimer has adjusted their stance on Guardian Pharmacy Service ( $GRDN ), setting the rating to Outperform with a target price of 30.
0 · Reply
scientificway
scientificway Sep. 3 at 4:14 PM
$GRDN Chance to get in before it shoots up
1 · Reply
scientificway
scientificway Aug. 27 at 5:50 PM
$GRDN strong buy, XTNT revenue up year over year. showing a strong support here and most likely going up from here.
0 · Reply
CapitalTrekker
CapitalTrekker Aug. 27 at 6:51 AM
$GRDN momentum slowing down, needs strength to push higher.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 12:14 PM
$GRDN https://www.benzinga.com/pressreleases/25/08/b46824763/guardian-pharmacy-services-strengthens-pacific-northwest-presence-with-acquisition-of-oregon-based
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 10:01 PM
$GRDN Outstanding article that hits the mark on GRDN's current state. So if you want to refresh your GRDN insights or learn about GRDN from scratch, this is a must read. https://beyondspx.com/article/guardian-pharmacy-services-tech-enabled-growth-in-long-term-care-nyse-grdn
0 · Reply
DonCorleone77
DonCorleone77 May. 23 at 10:19 AM
$GRDN Guardian Pharmacy 7.5M share Secondary priced at $21.00 The deal priced below last closing price of $22.58. Raymond James is acting as lead book running manager for the offering.
0 · Reply
briefingcom
briefingcom May. 21 at 12:04 PM
Gapping down: $WOLF -62.3% $VFC -13% $CRI -7.5% $GRDN -7.5% $CTRI -7.2%
0 · Reply
DonCorleone77
DonCorleone77 May. 20 at 8:34 PM
$GRDN Guardian Pharmacy announces 7.5M Class A common stock offering Guardian Pharmacy Services announced the launch of a proposed underwritten public offering of 7.5M shares of its Class A common stock, consisting of 6.06M shares being offered by certain selling stockholders and 1.44M newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the offering. Raymond James is acting as lead bookrunning manager of the offering and as representative of the underwriters for the proposed offering. Stephens Inc. and Truist Securities are acting as joint bookrunning managers for the offering.
0 · Reply
PenkeTrading
PenkeTrading May. 3 at 2:30 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Guardian Pharmacy Services, Inc.. Is that bullish or bearish? $GRDN #Guardian #RsiOverbought #NYSE
0 · Reply
JFDI
JFDI Apr. 25 at 12:37 AM
$GRDN IPO
0 · Reply
Doozio
Doozio Apr. 17 at 11:24 PM
If YO can’t $SII whuts going on? like n subscribe! then let’s get going on that $GRND discount code ends 2mro! Water that $GRDN Bums.
0 · Reply
IN0V8
IN0V8 Apr. 11 at 3:34 PM
$GRDN Truist Securities raises PT to $25 from $24
0 · Reply
JarvisFlow
JarvisFlow Apr. 11 at 1:00 PM
Truist Securities has updated their rating for Guardian Pharmacy Service ( $GRDN ) to Buy with a price target of 25.
0 · Reply
Doozio
Doozio Apr. 10 at 2:36 PM
$GRND appears like a wen not if 🐒🍌🧠 ⏰♾️. So keep $GRDN
2 · Reply
Doozio
Doozio Apr. 9 at 10:30 PM
$GRDN $GRND chop chop huckleberries scrabble bag it! N 🖕da 🐑 bums! There is only ☝️…..
0 · Reply